Urinary FOXP3 mRNA in patients with lupus nephritis - Relation with disease activity and treatment response

Rheumatology

Volumn 48, Issue 7, 2009, Pages 755-760

  Wang, Gang ^a   Lai, Fernand M M ^a   Tam, Lai Shan ^a   Li, Edmund K M ^a   Kwan, Bonnie C H ^a   Chow, Kai Ming ^a   Li, Philip K T ^a   Szeto, Cheuk Chun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cytokine; Lupus nephritis; SLE

Indexed keywords

ALBUMIN; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3;

ADULT; ALBUMINURIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MICROALBUMINURIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; REGULATORY T LYMPHOCYTE; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT RESPONSE; UPREGULATION; URINALYSIS; URINE SEDIMENT;

ACUTE DISEASE; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HUMANS; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PROTEINURIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; UP-REGULATION;

EID: 67650035003     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep074     Document Type: Article

References (33)

1. Cross J, Jayne D. Diagnosis and treatment of kidney disease. Best Pract Res Clin Rheumatol 2005;19:785-98.
2. Waldman M, Appel GB. Update on the treatment of lupus nephritis. Kidney Int 2006;70:1403-12.
3. Fiehn C, Hajjar Y, Mueller K, Waldherr R, Ho AD, Andrassy K. Improved clinical outcome of lupus nephritis during the past decade: Importance of early diagnosis and treatment. Ann Rheum Dis 2003;62:435-9.
4. Fontenot JD, Gavin MA, Rudensky AY. FOXp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003;4:330-6.
5. Sakaguchi S. Naturally arising FOXp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005;6:345-52.
6. Lee JH, Wang LC, Yang YH, Lin DT, Chiang BL. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology 2006;117:280-6.
7. Valencia X, Yarboro C, Illei G, Lipsky PE. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 2007;178:2579-88.
8. Lyssuk EY, Torgashina AV, Soloviev SK et al. Reduced number and function of CD4+CD25highFOXP3+ regulatory T cells in patients with systemic lupus erythematosus. Adv Exp Med Biol 2007;601:113-19.
9. Banham AH, Powrie FM, Suri-Payer E. FOXP3+ regulatory T cells: Current controversies and future perspectives. Eur J Immunol 2006;36:2832-6.
10. Bonelli M, von Dalwigk K, Savitskaya A, Smolen JS, Scheinecker C. FOXp3 expression in CD4+ T cells of patients with systemic lupus erythematosus (SLE): A comparative phenotypic analysis. Ann Rheum Dis 2008;67:664-71.
11. Schwartz N, Michaelson JS, Putterman C. Lipocalin-2, TWEAK, and other cytokines as urinary biomarkers for lupus nephritis. Ann N Y Acad Sci 2007;1109:265-74.
12. Wada T, Yokoyama H, Omosugi N et al. Detection of urinary interleukin-8 in glomerular diseases. Kidney Int 1994;46:455-60.
13. Muthukumar T, Dadhania D, Ding R et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005;353:2342-51.
14. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40:1725-6.
15. Chan RW, Tam LS, Li EK et al. Inflammatory cytokine gene expression in the urinary sediment of lupus nephritis patients. Arthritis Rheum 2003;48:1326-31.
16. Chan RW, Lai FM, Li EK et al. Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis. Arthritis Rheum 2004;50:2882-90.
17. Chan RW, Lai FM, Li EK et al. The effect of immunosuppressive therapy on the messenger RNA expression of target genes in the urinary sediment of patients with active lupus nephritis. Nephrol Dial Transplant 2006;21:1534-40.
18. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
19. Li B, Hartono C, Ding R et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001;344:947-54.
20. Szeto CC, Chan RW, Lai KB et al. Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases. Nephrol Dial Transplant 2005;20:105-13.
21. Weening JJ, D'Agati VD, Schwartz MM et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004;65:521-30.
22. Grande JP, Balow JE. Renal biopsy in lupus nephritis. Lupus 1998;7:611-17.
23. Bruneval P, Bariety J, Bélair MF, Mandet C, Heudes D, Nicoletti A. Mesangial expansion associated with glomerular endothelial cell activation and macrophage recruitment is developing in hyperlipidaemic apoE null mice. Nephrol Dial Transplant 2002;17:2099-107.
24. Chan RW, Lai FM, Li EK et al. Intra-renal cytokine gene expression in lupus nephritis. Ann Rheum Dis 2007;66:886-92.
25. Chan TM, Li FK, Tang CS et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med 2000;343:1156-62.
26. Crispin JC, Martinez A, Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2003;21:273-6.
27. Miyara M, Amoura Z, Parizot C et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 2005;175:8392-400.
28. Alvarado-Sanchez B, Hernandez-Castro B, Portales-Pérez D et al. Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2006;27: 110-18.
29. Walker MR, Kasprowicz DJ, Gersuk VH et al. Induction of FOXP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest 2003;112:1437-43.
30. Morgan M, van Bilsen JH, Bakker AM et al. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum Immunol 2005;66:13-20.
31. Ziegler SF. FOXP3 of mice and men. Annu Rev Immunol 2006;24:209-26.
32. Veronese F, Rotman S, Smith RN et al. Pathological and clinical correlates of FOXP3+ cells in renal allografts during acute rejection. Am J Transplant 2007;7:914-22.
33. Chan RW, Lai FM, Li EK et al. Urinary mononuclear cell and disease activity of systemic lupus erythematosus. Lupus 2006;15:262-7.